Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Collagen-Fibrin Patch (Tachosil®) for the Prevention of Symptomatic Lymphoceles After Pelvic Lymphadenectomy in Women With Gynecologic Malignancies: a Randomized Clinical Trial

NCT01470677 is registered in ClinicalTrials.gov with Ruhr University of Bochum as lead sponsor.

NCT NCT01470677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01470677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Collagen-Fibrin Patch (Tachosil®) for the Prevention of Symptomatic Lymphoceles After Pelvic Lymphadenectomy in Women With Gynecologic Malignancies: a Randomized Clinical Trial
Lead sponsor
Ruhr University of Bochum
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2011
Completion date
January 31, 2016
Enrollment
220 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, endometrial cancer